Cancer Solutions

MassARRAY System– highly accurate, sensitive analysis for Cancer Research

Sequenom offers a broad portfolio of solutions for cancer research from DNA methylation and gene expression, to somatic mutation and copy number analysis. At the heart is the MassARRAY® system, based on MALDI-TOF mass spectrometry. It enables highly accurate, sensitive, and high-throughput methods pivotal to cancer research. 

Applications for Cancer Research

Genotyping & Copy Number
Somatic mutation profiling
DNA Methylation
Gene Expression

Product Spotlight for Cancer Mutation Profiling

Sequenom now offers a growing number of cancer research panels for somatic mutation profiling. Use Assay Explorer™ to search through the OncoCarta™ Panel family.

OncoCarta™ v1.0—the first research panel for comprehensive oncogene analysis with 238 mutations and 19 genes

OncoCarta™ v2.0—an extended research panel for investigation of tyrosine kinase and cell signaling pathways such as CTNNB1 and MAP2K with 166 mutations and 18 genes

OncoCarta™ v3.0—a research panel with 105 mutations from 22 oncogenes and a number of tumor suppressors including PTEN, p53 and RB1

MelaCarta™ v1.0—a targeted research panel for melanoma cancer screening with 72 mutations and 20 genes

For more information, view our OncoCarta™ Webinaror view the MassARRAY® for Cancer Analysis Brochure

Recent Publications in the News

Search our Publication database by cancer disease, gene, or author to access the latest peer-reviewed publications using the MassARRAY® system for cancer research.